|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
December 2013 Volume 13 Number 12 | |||||||||||||||||||||||||||||||||||||||||||||||
| In this issue![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
| ||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
Comment: Nobel Prize discovery paves the way for immunological traffic Jennifer L. Stow p839 | doi:10.1038/nri3564 The 2013 Nobel Prize for Physiology or Medicine recognizes James Rothman, Randy Schekman and Thomas Sudhof, whose work over several decades has characterized key components and mechanisms of the trafficking machinery in eukaryotic cells. Reflecting on these Nobel Prize-winning discoveries raises some important and exciting prospects for immunologists. Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS | Top | ||||||||||||||||||||||||||||||||||||||||||||||
Studying immunity to zoonotic diseases in the natural host — keeping it real Andrew G. D. Bean, Michelle L. Baker, Cameron R. Stewart, Christopher Cowled, Celine Deffrasnes, Lin-Fa Wang & John W. Lowenthal p851 | doi:10.1038/nri3551 Immunology is traditionally viewed as a science of 'mice and men'. However, key insights can come from the study of immune responses in livestock or wild animals. The fact that the most deadly pathogens of humans are often zoonotic in nature lends further weight to the importance of this research. The authors discuss the benefits of, and challenges posed by, these studies. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||||||||||||
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy Richard S. Hotchkiss, Guillaume Monneret & Didier Payen p862 | doi:10.1038/nri3552 Sepsis is the host inflammatory response to severe, life-threatening infection with the presence of organ dysfunction, and is the most frequent cause of mortality in most intensive care units. Here, the authors argue that, following survival of the initial hyper-inflammatory response, the patient enters a protracted immunosuppressive phase and, therefore, that immunotherapies to treat prolonged sepsis must target the specific cellular dysfunctions associated with immunosuppression. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
Age-dependent dysregulation of innate immunity Albert C. Shaw, Daniel R. Goldstein & Ruth R. Montgomery p875 | doi:10.1038/nri3547 Ageing is associated with impaired immune responses to pathogens and vaccines. As described in this Review, ageing results in disrupted regulation of immune cell functions and innate immune receptor signalling, and in the establishment of a persistent pro-inflammatory milieu. The authors explain how this age-associated dysregulation might contribute to chronic inflammatory diseases in the elderly. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
The immunobiology of prion diseases Adriano Aguzzi, Mario Nuvolone & Caihong Zhu p888 | doi:10.1038/nri3553 Prions are infectious proteins that cause fatal neurodegenerative diseases. The prion itself is a misfolded conformer of a normal host protein, which explains why it is difficult for the immune system to respond to it effectively. The authors explain how prions evade, and indeed exploit, immune components to spread to the central nervous system, and they discuss the immunotherapies that are being developed to combat these lethal infections. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
CORRESPONDENCE | Top | ||||||||||||||||||||||||||||||||||||||||||||||
Primary lysis of eosinophils as a major mode of activation of eosinophils in human diseased tissues Carl Persson & Lena Uller p902 | doi:10.1038/nri3341-c1 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
Reply to Eosinophil cytolysis and release of cell-free granules Helene F. Rosenberg & Paul S. Foster p902 | doi:10.1038/nri3341-c2 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
miR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection Jae Il Shin & Michael Eisenhut p902 | doi:10.1038/nri3463-c1 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
Reply to miR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection Markus Heim p902 | doi:10.1038/nri3463-c2 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
![]() |
*2012 Journal Citation Report (Thomson Reuters, 2013) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
![]() |
No comments:
Post a Comment